Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depressionJournal of Affective Disorders · 2026-11-01Exploring the In Vitro Effect of Psilocybin on the Composition and Metabolic Activity of Gut Microbiota in Individuals with Severe AnxietyDrugs and Drug Candidates · 2026-08-12A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10A suite of engineered mice for interrogating psychedelic drug actions.Nature neuroscience · 2026-08-06Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanismsBehavioural Pharmacology · 2026-08-01The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-08-01Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trialCommunications Medicine · 2026-07-30An Open-Label, Phase 1 Study of the Safety Pharmacokinetic Profile, and Preliminary Efficacy, of Organic Whole Psilocybin-Containing Mushrooms in Patients Suffering From PTSDClinicalTrials.gov · 2026-07-29PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical TrialClinicalTrials.gov · 2026-07-10PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical TrialClinicalTrials.gov · 2026-07-10Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-07-01Improving access to novel treatments for treatment-resistant depression: The potential role of specialist clinics in Australia.The Australian and New Zealand journal of psychiatry · 2026-07-01Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults”PLOS One · 2026-06-30Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health careTranslational Psychiatry · 2026-06-23Psilocybin-Assisted Therapy for Prolonged GriefClinicalTrials.gov · 2026-06-23Dextromethorphan Beyond the Cough: Exploring Its Psychedelic Potential: A Systematic ReviewCNS Drugs · 2026-06-14Therapeutic advances in fibromyalgia: one year in review 2026.Clinical and experimental rheumatology · 2026-06-01265 Self-reported rates of psilocybin use in North Florida, 2012 to presentJournal of clinical and translational science · 2026-05-20Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal IdeationThe Journal of Clinical Psychiatry · 2026-05-131020 Long-term Impact of Psilocybin Administration on Sleep-Continuity via Wearable Sensor Time-series: Preliminary-results in Post-Treatment Lyme DiseaseSLEEPJ · 2026-05-08Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-07Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder: A Randomized Controlled TrialClinicalTrials.gov · 2026-05-01Effects of psychedelic use on authoritarian attitudes revisited.Journal of psychopharmacology (Oxford, England) · 2026-05-01Evaluating the evidence for repressed memory recovery in psychedelic contextsPsychopharmacology · 2026-04-28Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative review.BMJ supportive & palliative care · 2026-04-28Distinct Modulatory Effects on Affective Biases by Different Serotonergic Psychedelics and MDMA in Male Rats: Possible Implications for Antidepressant EffectsbioRxiv · 2026-04-22A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depressionNature Mental Health · 2026-04-06Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial.Headache · 2026-04-01Inhibition of cortico-amygdala projections underlies affective bias modification by psilocybinbioRxiv · 2026-03-04Pilot study of psilocybin in patients with post-treatment lyme diseaseScientific Reports · 2026-02-25Development and assessment of a psychedelic-assisted therapy music playlist for clinical trials: Theory, intentionality, and metricsJournal of Psychedelic Studies · 2026-02-12Placebo Effects in the Treatment of Depression-Implications for the Psychedelic Renaissance.Neurologic clinics · 2026-02-01The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant DepressionEmerging Minds Journal for Student Research · 2026-01-25Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanismsRepository for Publications and Research Data (ETH Zurich) · 2026-01-20Psilocybin for Treatment-Resistant OCD: A Randomized Controlled TrialPsyArXiv · 2026-01-15Psychedelic DrugsIntechOpen · 2026-01-01A novel psychedelic 5-HT receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer.Journal of psychopharmacology (Oxford, England) · 2026-01-01The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female MiceThe Journal of Neuroscience · 2025-12-10Psilocybin inhibits formalin-induced nociception through 5-hydroxytryptamine 2A receptor in rats.Behavioural pharmacology · 2025-12-01Griffiths et al.'s Study of Psilocybin with Religious Professionals: A Theological Response from a Christian Perspective.Psychedelic medicine (New Rochelle, N.Y.) · 2025-12-01Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experiencePsychedelics · 2025-11-20Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondentsPsychedelics · 2025-11-15Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot study.Journal of affective disorders · 2025-11-15Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.Translational psychiatry · 2025-10-31Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions.Psychiatry research · 2025-10-01Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative reviewClinical Neuropsychopharmacology and Addiction · 2025-09-24Psychedelics Relax Priors and Reshape Orbitofrontal DynamicsbioRxiv · 2025-09-19Active Constituents of Psilocybin Mushroom Edibles.JAMA network open · 2025-09-02Lifetime classic psychedelic use and headaches: A cross-sectional study.Journal of psychopharmacology (Oxford, England) · 2025-09-01Self-inflicted transorbital intracranial foreign body following ingestion of hallucinogenic psilocybin mushrooms.American journal of ophthalmology case reports · 2025-09-01Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resourcemedRxiv · 2025-08-16631. PSILOCYBIN AND KETANSERIN VS RTMS IN TREATMENT-RESISTANT DEPRESSION: ENHANCING TOLERABILITY BY MITIGATING PSYCHEDELIC EFFECTSThe international journal of neuropsychopharmacology · 2025-08-01Preparing Social Work for Psychedelic-Assisted TherapySocial Work · 2025-07-30Prolonged hallucinogenic effects following Psilocybe cubensis ingestion: Case reportThe poison. · 2025-06-30Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatmentsPsyArXiv · 2025-05-16Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatmentsPsyArXiv · 2025-05-16ALSUntangled #77: Psilocybin.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025-05-01Psilocybin for disorders of consciousness: A case-report study.Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology · 2025-05-01Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile AnalysisInternational Journal of Mental Health and Addiction · 2025-04-24630. Synthetic Psilocybin (COMP360) for Chronic Active Suicidal Ideation: An Open-Label StudyBiological Psychiatry · 2025-04-09Psilocybin’s Effects on Headache Frequency are Not Related to Acute Psychedelic Effects or Measures of Mental Health: Secondary Analysis of Clinical Trials in Migraine and Cluster Headache (P7-12.001)Neurology · 2025-04-07The psychedelic psilocybin and light exposure have similar and synergistic effects on gene expression patterns in the visual cortex.Molecular brain · 2025-03-18The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.Journal of affective disorders · 2025-03-01Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc AnalysisClinical Pharmacokinetics · 2025-03-01A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01High-quality draft genomes of ecologically and geographically diverse species.Microbiology resource announcements · 2025-02-11Direct effects of psilocybin on serotonin receptors regulate lipid accumulation in hepatic cells and adipocytesDigestive and Liver Disease · 2025-02-01Prevalence of Use of Psilocybin and MDMA in Multiple US CitiesDrug and Alcohol Dependence · 2025-02-01Self-reported experiences and perspectives on using psychedelics to manage opioid use among participants of two Reddit communities.Addiction (Abingdon, England) · 2025-01-16Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study.Journal of affective disorders · 2025-01-15Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial.The American journal of psychiatry · 2025-01-01Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc AnalysisClinical Pharmacokinetics · 2025-01-01Geographical Differences in Self-Reported Past 12-Month Drug Use: Results from the NDEWS Rapid Street Reporting, 2021-2023.Substance use & misuse · 2025-01-01: A new species from central Florida, with notes on and.Mycologia · 2025-01-01Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis.Frontiers in psychiatry · 2025-01-01Political Attitudes towards the Legalization of Cannabis and PsilocybinSSRN Electronic Journal · 2024-12-31Differential in Vitro Activation Profiles for Psychedelic versus Non-psychedelic Ergolines at the 5-HT2A ReceptorEmerging Trends in Drugs Addictions and Health · 2024-12-01Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trialPsyArXiv · 2024-11-04Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trialPsyArXiv · 2024-11-04Increased reactivity of the paraventricular nucleus of the hypothalamus and decreased threat responding in male rats following psilocin administrationUNC Libraries · 2024-10-22Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.The Cochrane database of systematic reviews · 2024-09-12Rapidly Trading Down Depression's 3 Pillars to 5HT3-Receptors Through ECT or Psilocybin?Psychiatria Danubina · 2024-09-01Psychedelics, Psychedelic-Assisted Therapy and Employees’ WellbeingJournal of Management Inquiry · 2024-08-28Selective Serotonin Reuptake Inhibitor Discontinuation for Psilocybin Treatment and Contributions to Alcohol Addiction Relapse: A Cautionary Tale.The Journal of clinical psychiatry · 2024-08-26Regional Differences of Self-Reported Past-12-month Marijuana, Psilocybin, and Cocaine Use: Results From NDEWS Rapid Street Reporting 2021-2022Drug and Alcohol Dependence · 2024-07-01Acute Psychedelic Effects and Clinical Outcomes are Associated With Therapeutic Alliance Among Participants Receiving Psilocybin TherapyDrug and Alcohol Dependence · 2024-07-01Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or PsilocybinDrug and Alcohol Dependence · 2024-07-01What is needed for the roll-out of psychedelic treatments?Current opinion in psychiatry · 2024-07-01Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.JAMA psychiatry · 2024-06-01Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety-Reply.JAMA psychiatry · 2024-06-01THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLDJournal of Hepatology · 2024-05-31Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptor.iScience · 2024-05-17Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial.Journal of the neurological sciences · 2024-05-15National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022.Drug and alcohol dependence · 2024-05-01Use of Prescribed and Non-Prescribed Treatments for Cluster Headache in a Swedish Cohort.Brain sciences · 2024-03-31Ethical considerations for psychedelic-assisted therapy in military clinical settings.Journal of medical ethics · 2024-03-20New evidence for flexible psilocybin dosing in patients with treatment-resistant depression.Med (New York, N.Y.) · 2024-03-08Development of a digital intervention for psychedelic preparation (DIPP).Scientific reports · 2024-02-19Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLDDigestive and Liver Disease · 2024-02-01Determination of psilocybin and psilocin content in multiple Psilocybe cubensis mushroom strains using liquid chromatography - tandem mass spectrometryAnalytica Chimica Acta · 2024-02-01RAPIDLY TRADING DOWN DEPRESSION'S3 PILLARS TO 5HT3-RECEPTORS THROUGH ECT OR PSILOCYBIN?University of Zagreb University Computing Centre (SRCE) · 2024-01-01Psilocybin Without Psychotherapy: A Cart Without a Horse?The American journal of psychiatry · 2024-01-01CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity.Headache · 2024-01-01The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.Current neuropharmacology · 2024-01-01Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.Frontiers in psychiatry · 2024-01-01The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder.PloS one · 2024-01-01Within-subject comparison of near-death and psychedelic experiences: acute and enduring effects.Neuroscience of consciousness · 2024-01-01Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences.Journal of psychoactive drugs · 2024-01-01Fire Kasina advanced meditation produces experiences comparable to psychedelic and near-death experiences: A pilot study.Explore (New York, N.Y.) · 2024-01-01Development of a Digital Intervention for Psychedelic Preparation (DIPP): a theory- and person-centred approachPsyArXiv · 2023-11-22A "Magic Mushroom" Multi-Product Sesquiterpene Synthase.Chembiochem: a European journal of chemical biology · 2023-11-02Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results.Neuroscience and biobehavioral reviews · 2023-11-01[Psychedelics and treatment of mental disorders: A survey of attitudes and knowledge among psychiatrists, general practitioners and psychologists in Iceland].Laeknabladid · 2023-11-01Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?Clinical Pharmacology & Therapeutics · 2023-10-05Psychedelics, With a Focus on Psilocybin: Issues for the Clinician.Journal of psychiatric practice · 2023-09-01Applying Key Lessons from the Hospice and Palliative Care Movement to Inform Psychedelic-Assisted Therapy.Psychedelic medicine (New Rochelle, N.Y.) · 2023-09-01Introduction to the chemistry and pharmacology of psychedelic drugsAustralian Journal of Chemistry · 2023-07-04Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.Neuropharmacology · 2023-06-15Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.Nature neuroscience · 2023-06-01TMS-EEG and resting-state EEG applied to altered states of consciousness: oscillations, complexity, and phenomenology.iScience · 2023-05-19Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD.BMJ open · 2023-05-04Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.Journal of affective disorders · 2023-04-1496. An Open Label Study of Synthetic Psilocybin in Bipolar Type II DepressionBiological Psychiatry · 2023-04-10Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation.Journal of affective disorders · 2023-04-01Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?Clinical Chemistry · 2023-03-07Research into Psychedelic-Assisted Psychotherapy for Anorexia Nervosa Should be Funded.Journal of bioethical inquiry · 2023-03-01Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial.Frontiers in psychiatry · 2023-01-01Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective.Frontiers in psychiatry · 2023-01-01Assessing potential of psilocybin for depressive disorders.Expert opinion on investigational drugs · 2023-01-01Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.Frontiers in psychiatry · 2023-01-01Psilocybin for Depression: From Credibility to Feasibility, What's Missing?Pharmaceuticals (Basel, Switzerland) · 2022-12-31Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice.ACS pharmacology & translational science · 2022-11-11Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.Headache · 2022-11-01Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.JAMA psychiatry · 2022-10-01The Emerging Field of Psychedelic Psychotherapy.Current psychiatry reports · 2022-10-01Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language ProcessingPsyArXiv · 2022-09-30Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17[The use of psilocybin for treatment-resistant depression].Laeknabladid · 2022-09-01Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.Journal of palliative medicine · 2022-08-01Assessment of Bioactivity-Modulating Pseudo-Ring Formation in Psilocin and Related TryptaminesChemBioChem · 2022-07-05Psilocybin-induced takotsubo cardiomyopathy.BMJ case reports · 2022-05-17P388. Open Label Psilocybin Administration in Severely Treatment Resistant DepressionBiological Psychiatry · 2022-04-27The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trialNeuroscience Applied · 2022-01-01The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trialNeuroscience Applied · 2022-01-01A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy.Frontiers in psychiatry · 2022-01-01A Qualitative Exploration of Relational Ethical Challenges and Practices in Psychedelic HealingJournal of Humanistic Psychology · 2021-09-16Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use DisordersCanadian Agency for Drugs and Technologies in Health, Ottawa (ON) · 2021-06-01Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.Proceedings of the National Academy of Sciences of the United States of America · 2021-04-27[Ketamine, psilocybin, and rapid acting antidepressant: new promise for psychiatry?].L'Encephale · 2021-04-01Draft Genome Sequence of the Termite-Associated "Cuckoo Fungus," () sp. TMB Strain TB5.Microbiology resource announcements · 2021-01-07Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics · 2021-01-01People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences.Drugs (Abingdon, England) · 2021-01-01A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted TherapyPsyArXiv · 2020-10-28The use of psychedelics in the treatment of disorders of consciousness. An interview with Olivia Gosseries by Charlotte Martial.Open Repository and Bibliography (University of Liège) · 2020-10-12Nothing Ventured, Nothing Gained: Regulations Cripple Potentially Life-Saving Research of Illicit Substances.ACS chemical neuroscience · 2020-05-20Isness: Using Multi-Person VR to Design Peak Mystical Type Experiences Comparable to PsychedelicsProceedings of the 2020 CHI Conference on Human Factors in Computing Systems · 2020-04-20Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in "Magic" Mushrooms.Chemistry (Weinheim an der Bergstrasse, Germany) · 2020-01-13Self-Reported Illicit Drug Use Among Norwegian University and College Students. Associations With Age, Gender, and Geography.Frontiers in psychiatry · 2020-01-01Replication and extension of a model predicting response to psilocybin.Psychopharmacology · 2019-11-01Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin.NeuroImage · 2019-10-01Unpredictable Behavior Under the Influence of "Magic Mushrooms": A Case Report and Review of the Literature.Journal of forensic sciences · 2019-07-01Psychedelics as a treatment for disorders of consciousness.Neuroscience of consciousness · 2019-01-01Entheogene Pilze: Welches Potential bietet die psychoaktive Substanz Psilocybin für die moderne Psychotherapie in Forschung und Praxis? / Sophie-Charlotte Alice AdlerUniversity of Innsbruck · 2018-08-01Altered trajectories in the dynamical repertoire of functional network states under psilocybinbioRxiv · 2018-07-25High dose psilocybin is associated with positive subjective effects in healthy volunteers.Journal of psychopharmacology (Oxford, England) · 2018-07-01Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study.Frontiers in psychology · 2018-01-01Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.Clinical pharmacokinetics · 2017-12-01Should addiction researchers be interested in psychedelic science?Drug and Alcohol Review · 2017-04-10MAGIC MUSHROOMS: from sacred entheogen to Class A drugEntertainment and Sports Law Journal · 2016-06-26The “Endless Trip”: Psychopathology and psychopharmacology in the Hallucinogen Persisting Perception Disorder (HPPD)European Psychiatry · 2016-02-29Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey.Journal of psychoactive drugs · 2015-01-01Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in HumansPLoS ONE · 2010-12-01Other Times I Can Barely See: The Effects of Hallucinogens on Vision and AttentioneScholarship (California Digital Library) · 2009-12-31Availability of websites offering to sell psilocybin spores and psilocybin.Journal of psychoactive drugs · 2009-09-01Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.Addictive behaviors · 2004-06-01Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2003-01-01Patterns of recreational drug use at dance events in Edinburgh, Scotland.Addiction (Abingdon, England) · 2001-07-01Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 1990-04-01The quantitation of psilocybin in hallucinogenic mushrooms using high performance liquid chromatography.Journal of forensic sciences · 1983-10-01The danger of hallucinogenic mushrooms.Scottish medical journal · 1979-10-01Severe aggression in rats induced by mescaline but not other hallucinogens.Psychopharmacology · 1979-01-01Psilocin, Bufotenine and Serotonin: Historical and Biosynthetic ObservationsJournal of Psychedelic Drugs · 1979-01-01Detection of psilocybin in species of Psilocybe, Panaeolus and Psathyrella.Lloydia · 1976-01-01The effect of psilocybin upon the systemic, pulmonary, and coronary circulation of the intact dog.Archives internationales de pharmacodynamie et de therapie · 1962-05-01Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen RauschpilzenHelvetica Chimica Acta · 1959-01-01[Elucidation of the structure and the synthesis of psilocybin].Experientia · 1958-11-15